New heart failure drug shows promise in hospitalized patients
Disease control
Ongoing
This study tests an investigational drug called COR-1167 in 300 people hospitalized with worsening heart failure. Participants receive either the drug or a placebo for 28 days. Researchers measure how well the body removes fluid, changes in weight, heart function, and symptoms. T…
Phase: PHASE2 • Sponsor: Corteria Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC